about
Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution.An amphipathic alpha-helix at a membrane interface: a structural study using a novel X-ray diffraction method.Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice.Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases.Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis.Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptidesCrystal structure of the channel-forming polypeptide antiamoebin in a membrane-mimetic environment.Synthetic peptides: managing lipid disorders.Atherosclerosis and vascular disease: effects of peptide mimetics of apolipoproteins.Effect of leucine to phenylalanine substitution on the nonpolar face of a class A amphipathic helical peptide on its interaction with lipid: high resolution solution NMR studies of 4F-dimyristoylphosphatidylcholine discoidal complex.HDL therapy for cardiovascular diseases: the road to HDL mimetics.Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in ratsStructural insight into the role of the human melanocortin 3 receptor cysteine residues on receptor function.Third transmembrane domain of the adrenocorticotropic receptor is critical for ligand selectivity and potency.Anti-inflammatory peptides grab on to the whiskers of atherogenic oxidized lipids.An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes.ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers.Studies of kinetics and equilibrium membrane binding of class A and class L model amphipathic peptides.Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide.Interaction of model class A1, class A2, and class Y amphipathic helical peptides with membranesMolecular basis for prokaryotic specificity of magainin-induced lysisEffect of the arrangement of tandem repeating units of class A amphipathic alpha-helixes on lipid interactionMolecular characterization of human melanocortin-5 receptor ligand-receptor interaction
P50
Q30497594-BC2BF609-7B84-4D54-A9C9-C16FB174C544Q30535428-7ABB1110-B1F7-4F9A-926D-3E0F09D4E5ABQ33420925-A382ACD0-BBD8-462E-BB5A-8F5A88D731E7Q33866553-BD8BC79B-C171-4F00-9A83-A8383D189AB5Q34287846-EE834AC5-98B3-4369-A65C-12EDC915C74FQ34478920-ECADC8AD-D22B-4D5F-9600-547864B94232Q34731730-6B17DF81-E3E5-4EFD-9749-242BE4FB10C4Q35897017-68016181-A497-49C4-A9CD-6CE7B682D02EQ36089557-06AB33D3-EA36-4A7D-9315-69CD0102B9D3Q36470848-AB0674FF-4B66-44F1-B657-AC1E43C674BFQ36570160-49281748-469F-416E-8403-1B9C867E7D61Q36990191-099E681C-E10B-4034-8C2D-06AB7AE10B98Q37244748-D9899E80-C2FE-4FE9-8349-B856F5563F6FQ37401827-D5E37148-28F5-46E2-A68E-83F815158AF0Q39908004-3940CBA4-727C-4FD1-B27B-5AFA8DDE636EQ41552581-B755C0D5-157C-4A55-8CC1-8056A33F0938Q41974849-D3CF73DE-78E3-4C8F-B660-00AB1184B022Q46119869-21CDED64-F366-4F99-98FC-9BDAAB13E5F9Q46650186-B818BFB2-53F4-43D3-96B9-A844F5BCADFDQ47838690-5B464551-37A7-44B0-AD6C-329A754AC9C3Q51776269-BBC56358-ACCD-465C-9A29-E3C2E7FA6812Q52529061-DB9F66C7-BFF7-4F59-93B5-0BE5110CFB14Q53667385-9251D0AD-DF52-447D-A233-92E99833F257Q71466186-46D97B5D-7AB7-4C98-81B1-846F37142BF9Q72125585-B38F9D09-9E30-4A08-A2D7-905135562EB9Q72428561-ADDAA65F-BE5F-4CFF-A983-287B4E7CCEA5Q86130115-FA871346-6FED-4B0D-B64B-E81CB245763C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vinod K Mishra
@nl
Vinod K Mishra
@sl
Vinod K. Mishra
@en
Vinod K. Mishra
@es
type
label
Vinod K Mishra
@nl
Vinod K Mishra
@sl
Vinod K. Mishra
@en
Vinod K. Mishra
@es
prefLabel
Vinod K Mishra
@nl
Vinod K Mishra
@sl
Vinod K. Mishra
@en
Vinod K. Mishra
@es
P106
P1153
35902377400
P31
P496
0000-0002-4527-1512